Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparison of the pharmacodynamics and pharmacokinetics of insulin aspart and human soluble insulin in geriatric subjects with type 2 diabetes mellitus.

Trial Profile

Comparison of the pharmacodynamics and pharmacokinetics of insulin aspart and human soluble insulin in geriatric subjects with type 2 diabetes mellitus.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Insulin aspart (Primary) ; Insulin
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 06 May 2009 Actual patient number (19) added as reported by ClinicalTrials.gov.
    • 06 May 2009 Actual end date (Jul 2002) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top